Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

Boyarsky, 2021, Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients, JAMA., 325, 2204, 10.1001/jama.2021.7489 Rozen-Zvi, 2021, Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study, Clin Microbiol Infect., 27, 10.1016/j.cmi.2021.04.028 Cucchiari, 2021, Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients, Am J Transplant., 21, 2727, 10.1111/ajt.16701 Grupper, 2021, Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus, Am J Transplant., 21, 2719, 10.1111/ajt.16615 Benotmane, 2021, Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine, Kidney Int., 99, 1498, 10.1016/j.kint.2021.04.005 Chavarot, 2021, Poor Anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept, Transplantation., 105, e94, 10.1097/TP.0000000000003784 Ou MT, Boyarsky BJ, Motter JD, et al. Safety and reactogenicity of 2 doses of SARS-CoV-2 vaccination in solid organ transplant recipients. Transplantation. 2021. https://doi.org/10.1097/TP.0000000000003780 Bertrand D, Hamzaoui M, Lemée V, et al. Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients. J Am Soc Nephrol. 2021. https://doi.org/10.1681/ASN.2021040480 Caillard, 2021, Occurrence of severe COVID-19 in vaccinated transplant patients, Kidney Int., 100, 477, 10.1016/j.kint.2021.05.011 Ali, 2021, Development of COVID-19 infection in transplant recipients after SARS-CoV-2 vaccination, Transplantation., 105, e104, 10.1097/TP.0000000000003836 Tsalouchos A, Rossolini GM, Maggi L, Mazzoni A, Annunziato F, Dattolo PC. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination. Transpl Infect Dis. 2021. https://doi.org/10.1111/tid.13649 Tsapepas, 2021, Clinically significant COVID-19 following SARS-CoV-2 vaccination in kidney transplant recipients, Am J Kidney Dis., 78, 314, 10.1053/j.ajkd.2021.05.004 DGS-Urgent. Vaccins contre la Covid-19: modalites d’administration des rappels. https://www.mesvaccins.net/textes/dgs_urgent_n43_vaccination_modalites_d_administration_des_rappels.pdf. Published 2021. Accessed November 4, 2021. Kamar, 2021, Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients, N Engl J Med., 385, 661, 10.1056/NEJMc2108861 Ebinger, 2021, Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2, Nat Med., 27, 981, 10.1038/s41591-021-01325-6 Gäckler, 2020, Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab, Nephrol Dial Transplant., 35, 298 Harritshøj LH, Gybel-Brask M, Afzal S, et al. Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories. J Clin Microbiol. 2021. https://doi.org/10.1128/JCM.02596-20 Leibler, 2018, Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk, J Am Soc Nephrol., 29, 1049, 10.1681/ASN.2017060679 Chen, 2013, Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig: endogenous alloreactive B cell responses, Am J Transplant., 13, 2280, 10.1111/ajt.12350 Sattler, 2020, SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition, J Clin Invest., 130, 6477, 10.1172/JCI140965 Caillard, 2021, Is COVID-19 infection more severe in kidney transplant recipients?, Am J Transplant., 21, 1295, 10.1111/ajt.16424 Chavarot, 2021, COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities, Am J Transplant., 21, 1285, 10.1111/ajt.16416 Toapanta, 2021, Kidney transplantation and COVID-19 renal and patient prognosis, Clin Kidney J., 14, i21, 10.1093/ckj/sfab030 Malinis, 2021, Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients, Am J Transplant., 21, 2916, 10.1111/ajt.16713 Qin CX, Moore LW, Anjan S, et al. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021. https://doi.org/10.1097/TP.0000000000003907 Elias, 2020, COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes, J Am Soc Nephrol., 31, 2413, 10.1681/ASN.2020050639 Chavarot, 2021, COVID-19: a one-center experience in Paris, Transplant Direct., 7, e647, 10.1097/TXD.0000000000001066 Jin, 2021, Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals, Sci Immunol., 6, eabg0791, 10.1126/sciimmunol.abg0791 Araki, 2009, mTOR regulates memory CD8 T-cell differentiation, Nature., 460, 108, 10.1038/nature08155 Ray, 2015, The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T Helper 1 and follicular B helper T cells, Immunity., 43, 690, 10.1016/j.immuni.2015.08.017